News from cardiome pharma corp A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

( NASDAQ-NMS:CRME,Toronto:COM)

Jan 27, 2016, 08:00 ET

Cardiome Announces Filing of Orphan Drug Application for Oral Vernakalant with U.S. FDA

NASDAQ: CRME   TSX: COM VANCOUVER, Jan. 27, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it...

Jan 21, 2016, 08:00 ET

Cardiome Announces the Launch of ESMOCARD LYO in Belgium

NASDAQ: CRME   TSX: COM VANCOUVER, Jan. 21, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced...

Jan 13, 2016, 08:00 ET

Cardiome announces filing of marketing authorization application for intravenous vernakalant in the Kingdom Of Saudi Arabia

NASDAQ: CRME TSX: COM VANCOUVER, Jan. 13, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that a Marketing...

Jan 12, 2016, 09:19 ET

Cardiome Announces Share Purchase Agreement with Lincoln Park Capital Fund, LLC

NASDAQ: CRME    TSX: COM VANCOUVER, Jan. 12, 2016 /PRNewswire/ - Cardiome Pharma Corp. ("Cardiome" or the "Company") (NASDAQ: CRME...

Jan 06, 2016, 08:00 ET

Cardiome and SteadyMed Announce Decision for Centralized Review of Trevyent® by the European Medicines Agency

VANCOUVER, BC and SAN RAMON, CA, Jan. 6, 2016 /PRNewswire/ - Cardiome Pharma Corp. (Nasdaq: CRME, TSX: COM) and SteadyMed Ltd. (Nasdaq: STDY),...

Jan 05, 2016, 08:00 ET

Cardiome Enters Commercialization Agreement with Chong Kun Dang for BRINAVESS® in South Korea

NASDAQ: CRME     TSX: COM VANCOUVER, Jan. 5, 2016 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today...

Dec 22, 2015, 16:15 ET

Cardiome Files New Drug Submission Seeking Canadian Approval of intravenous vernakalant

NASDAQ: CRME TSX: COM VANCOUVER, Dec. 22, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the filing of a...

Nov 13, 2015, 07:00 ET

Cardiome Reports Third Quarter 2015 Financial Results

Cardiome to conduct conference call and webcast today, November 13, 2015 at 8:00 a.m. Eastern (5:00 a.m. Pacific) NASDAQ: CRME TSX:...

Nov 06, 2015, 08:00 ET

Cardiome to Hold Third Quarter 2015 Financial Results Conference Call on November 13

NASDAQ: CRME   TSX: COM VANCOUVER, Nov. 6, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that...

Sep 30, 2015, 08:00 ET

Cardiome and Mitsubishi Tanabe Pharma Europe Enter Into an AGGRASTAT and EXEMBOL Co-Promotion Agreement in the UK

NASDAQ: CRME   TSX: COM VANCOUVER, Sept. 30, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that...

Sep 08, 2015, 08:00 ET

Cardiome announces addition of Robert James Meyer, M.D. to board of directors

NASDAQ: CRME TSX: COM VANCOUVER, Sept. 8, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that Robert James...

Aug 27, 2015, 08:00 ET

Cardiome to Present at the 17th Annual Rodman & Renshaw Global Investment Conference

NASDAQ: CRME   TSX: COM VANCOUVER, Aug. 27, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that Dr....

Aug 24, 2015, 08:00 ET

Cardiome Expands Partnership with Eddingpharm to Commercialize AGGRASTAT in China

NASDAQ: CRME   TSX: COM VANCOUVER, Aug. 24, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that its...

Aug 10, 2015, 08:00 ET

United Kingdom Department of Health Sets BRINAVESS Pricing

NASDAQ: CRME    TSX: COM VANCOUVER, Aug. 10, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) is pleased to...

Aug 05, 2015, 07:00 ET

Cardiome Reports Second Quarter 2015 Financial Results

NASDAQ: CRME TSX: COM Cardiome to conduct conference call and webcast today, August 5, 2015 at 8:00 a.m. Eastern (5:00 a.m. Pacific) VANCOUVER,...

Jul 28, 2015, 08:00 ET

Cardiome to Hold Second Quarter 2015 Financial Results Conference Call on August 5

NASDAQ: CRME   TSX: COM VANCOUVER, July 28, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it...

Jul 24, 2015, 08:00 ET

Cardiome Partner Eddingpharm to Initiate BRINAVESS Phase I Study in China

NASDAQ: CRME   TSX: COM VANCOUVER, July 24, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced...

Jul 22, 2015, 08:00 ET

Cardiome Submits Supplemental New Drug Submission (sNDS) For AGGRASTAT To Health Canada

NASDAQ: CRME   TSX: COM VANCOUVER, July 22, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced that it...

Jun 29, 2015, 12:00 ET

SteadyMed and Cardiome Enter into a License Agreement for the Commercialization Rights to Trevyent® Outside the U.S.

SAN RAMON, CA and VANCOUVER, June 29, 2015 /PRNewswire/ - SteadyMed Ltd. (Nasdaq: STDY), a specialty pharmaceutical company focused on...

Jun 24, 2015, 08:30 ET

Cardiome Pharma Corp. Announces Voting Results

NASDAQ: CRME   TSX: COM VANCOUVER, June 24, 2015 /PRNewswire/ - Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the...